Albemarle (ALB) Slides As Undervalued Narrative Faces A Fresh Test

Albemarle Corporation

Albemarle Corporation

ALB

0.00

Recent Performance Puts Albemarle In Focus

Albemarle (ALB) has drawn investor attention after a difficult stretch for the stock, with shares down about 5% over the past day, 15% over the past week, and roughly 24% over the past month.

At the latest share price of $133.70, Albemarle’s short term momentum has clearly cooled, with the 30 day share price return down 24.21%, even as the 1 year total shareholder return of 116.23% points to a much stronger recent past.

If Albemarle’s recent swings have you thinking about related opportunities in materials and energy storage, it could be worth scanning 30 best rare earth metal stocks

With Albemarle shares under pressure but screens suggesting a large intrinsic discount and a wide gap to analyst targets, the key question is simple: is this weakness a potential entry point, or is the market already accounting for future growth?

Most Popular Narrative: 37.2% Undervalued

At a last close of $133.70 versus a narrative fair value of $212.74, Albemarle is framed as materially undervalued, with that gap hinging on a specific set of growth and margin expectations.

The analysts have a consensus price target of $212.74 for Albemarle based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $264.0, and the most bearish reporting a price target of just $83.28.

The fair value hinges on a sharp swing from losses to sizeable profits, supported by moderate revenue growth and much higher margins over time. The story also incorporates a specific future earnings level, a tighter range for share count, and a particular earnings multiple that currently sits below the wider sector. Curious which assumptions really move that $212.74 figure, and how sensitive the outcome is to even small changes in growth or margins?

Result: Fair Value of $212.74 (UNDERVALUED)

However, Albemarle’s story could shift if lithium prices remain weak for an extended period or if industry oversupply continues to erode pricing power and future margins.

Another View On Albemarle’s Valuation

While the analyst narrative points to Albemarle being 37.2% undervalued relative to a fair value of $212.74, the picture looks different when you look at simple sales based metrics.

Albemarle trades on a P/S ratio of 2.9x versus 1.1x for the wider US Chemicals industry and exactly 2.9x for its peer group. Our fair ratio estimate is 1.9x, which suggests the market is already assigning a richer multiple than that fair ratio implies. This may indicate valuation risk creeping in, or it may simply reflect the price of owning a leading lithium producer.

NYSE:ALB P/S Ratio as at Jun 2026
NYSE:ALB P/S Ratio as at Jun 2026

Next Steps

Given the mixed tone around Albemarle’s recent performance and valuation signals, it makes sense to move quickly, review the full data set, and test whether the risks and rewards align with your own expectations by checking the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Albemarle?

If Albemarle has sharpened your attention on valuation, risk and income, do not stop here. Broaden your watchlist with targeted stock ideas built from the Simply Wall St screener.

  • Spot potential mispricings early by scanning 44 high quality undervalued stocks that pair strong fundamentals with prices that still look compressed.
  • Strengthen your income stream by reviewing 8 dividend fortresses that combine higher yields with an emphasis on durability.
  • Sleep a little easier by focusing on 69 resilient stocks with low risk scores where balance sheets and risk scores work together to prioritize resilience first.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.